Company profile: Gritstone Bio
1.1 - Company Overview
Company description
- Provider of immunotherapies for cancer and infectious diseases, including GRANITE, a personalized neoantigen vaccine for solid tumors; SLATE, an off-the-shelf shared-neoantigen immunotherapy for KRAS-driven tumors; CORAL, prophylactic vaccines using self-amplifying mRNA; an HIV vaccine collaboration with Gilead; and EDGE, an AI platform to identify T cell targets.
Products and services
- EDGE™: An AI-driven platform designed to identify T cell targets for developing cancer immunotherapies and vaccines against infectious diseases
- GRANITE: A personalized neoantigen-based vaccine for treating solid tumors, currently evaluated in a Phase 2/3 study for metastatic, microsatellite-stable colorectal cancer patients
- SLATE: An off-the-shelf immunotherapy program utilizing shared neoantigens across patients to treat solid tumors, specifically targeting KRAS-driven tumor types
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gritstone Bio
Romark
HQ: United States
Website
- Description: Provider of small-molecule therapies for infectious diseases and cancers, offering Alinia (nitazoxanide) for diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 1+; investigational NT-300 for COVID-19 and other viral respiratory illnesses; clinical trials and R&D in viral, cancer, pain, neurodegenerative and aging-related diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Romark company profile →
Achaogen
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development, discovering and developing broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Achaogen company profile →
Lodo Therapeutics
HQ: United States
Website
- Description: Provider of drug discovery and development focused on creating naturally derived novel therapeutics to impact global human health, working in partnership with global pharmaceutical companies and leading NGOs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lodo Therapeutics company profile →
Enochian Biopharma
HQ: United States
Website
- Description: Provider of biotechnology, operating as a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enochian Biopharma company profile →
GlycoVaxyn
HQ: Switzerland
Website
- Description: Provider of biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology, developing and manufacturing immunogenic glycoprotein conjugate vaccines for a range of bacterial diseases, including pneumococcal and nosocomial infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlycoVaxyn company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gritstone Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gritstone Bio
2.2 - Growth funds investing in similar companies to Gritstone Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gritstone Bio
4.2 - Public trading comparable groups for Gritstone Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →